Quick Ratios
Quarterly Results
Profit & Loss
Balance Sheet
Cash Flow
Ratios
Mkt Cap
Market Capitalization
₹23,516Cr
Rev Gr TTM
Revenue Growth TTM
-3.43%
Peer Comparison
Compare up to 10 companies side by side across valuation, profitability, and growth.

DEEPAKNTR
VS
| Quarter | Mar 2023 | Jun 2023 | Sep 2023 | Mar 2024 | Jun 2024 | Sep 2024 | Mar 2025 | Jun 2025 | Sep 2025 |
|---|
|
Growth YoY Revenue Growth YoY% | 4.8 | -14.1 | -9.4 | 0.9 | 8.4 | 22.5 | 14.3 | -5.3 | 2.5 | -12.8 | -6.4 | 3.8 |
| 1,613 | 1,559 | 1,476 | 1,705 | 1,825 | 1,858 | 1,734 | 1,735 | 1,863 | 1,700 | 1,698 | 1,764 |
Operating Profit Operating ProfitCr |
| 17.7 | 11.9 | 17.0 | 15.2 | 14.2 | 14.3 | 14.6 | 8.8 | 14.5 | 10.0 | 10.7 | 10.7 |
Other Income Other IncomeCr | 13 | 32 | 17 | 14 | 99 | 19 | 21 | 21 | 23 | 25 | 20 | -4 |
Interest Expense Interest ExpenseCr | 4 | 2 | 3 | 3 | 4 | 6 | 6 | 6 | 9 | 8 | 8 | 11 |
Depreciation DepreciationCr | 41 | 38 | 39 | 42 | 46 | 47 | 48 | 48 | 51 | 51 | 53 | 58 |
| 315 | 202 | 277 | 274 | 349 | 275 | 264 | 135 | 279 | 155 | 163 | 138 |
| 81 | 52 | 72 | 72 | 95 | 72 | 70 | 37 | 76 | 42 | 44 | 38 |
|
Growth YoY PAT Growth YoY% | -12.5 | -36.1 | 17.5 | -3.4 | 8.6 | 35.1 | -5.3 | -51.4 | -20.2 | -44.6 | -38.9 | 1.7 |
| 11.9 | 8.5 | 11.5 | 10.1 | 11.9 | 9.3 | 9.6 | 5.2 | 9.3 | 5.9 | 6.2 | 5.0 |
| 17.1 | 11.0 | 15.0 | 14.8 | 18.6 | 14.8 | 14.2 | 7.2 | 14.8 | 8.2 | 8.7 | 7.3 |
| Financial Year | Mar 2015 | Mar 2016 | Mar 2017 | Mar 2018 | Mar 2019 | Mar 2020 | Mar 2021 | Mar 2022 | Mar 2023 | Mar 2024 | Mar 2025 | TTM |
|---|
|
| | 3.5 | -0.2 | 20.5 | 63.5 | 56.7 | 3.1 | 56.0 | 17.2 | -3.6 | 7.8 | -4.0 |
| 1,188 | 1,206 | 1,235 | 1,455 | 2,286 | 3,204 | 3,113 | 5,199 | 6,683 | 6,559 | 7,190 | 7,025 |
Operating Profit Operating ProfitCr |
| 10.5 | 12.2 | 9.9 | 11.9 | 15.3 | 24.3 | 28.6 | 23.6 | 16.2 | 14.6 | 13.2 | 11.6 |
Other Income Other IncomeCr | 2 | 2 | 81 | 12 | 15 | 35 | 22 | 43 | 48 | 156 | 84 | 63 |
Interest Expense Interest ExpenseCr | 38 | 40 | 34 | 45 | 83 | 115 | 74 | 34 | 25 | 12 | 28 | 36 |
Depreciation DepreciationCr | 36 | 40 | 48 | 53 | 78 | 140 | 153 | 178 | 166 | 166 | 195 | 213 |
| 67 | 89 | 135 | 111 | 268 | 806 | 1,042 | 1,434 | 1,146 | 1,102 | 953 | 734 |
| 14 | 26 | 38 | 32 | 94 | 195 | 266 | 368 | 294 | 291 | 255 | 201 |
|
| | 18.7 | 53.1 | -18.0 | 119.8 | 251.8 | 27.0 | 37.5 | -20.1 | -4.8 | -14.0 | -23.5 |
| 4.0 | 4.6 | 7.0 | 4.8 | 6.4 | 14.4 | 17.8 | 15.7 | 10.7 | 10.6 | 8.4 | 6.7 |
| 5.1 | 5.8 | 8.2 | 6.0 | 12.7 | 44.8 | 56.9 | 78.2 | 62.5 | 59.5 | 51.1 | 39.1 |
| Financial Year | Mar 2015 | Mar 2016 | Mar 2017 | Mar 2018 | Mar 2019 | Mar 2020 | Mar 2021 | Mar 2022 | Mar 2023 | Mar 2024 | Mar 2025 | Sep 2025 |
|---|
Equity Capital Equity CapitalCr | 21 | 23 | 26 | 27 | 27 | 27 | 27 | 27 | 27 | 27 | 27 | 27 |
| 325 | 450 | 689 | 895 | 1,044 | 1,545 | 2,319 | 3,311 | 4,063 | 4,769 | 5,361 | 5,488 |
Current Liabilities Current LiabilitiesCr | 484 | 598 | 807 | 1,048 | 884 | 749 | 553 | 747 | 794 | 785 | 923 | 887 |
Non Current Liabilities Non Current LiabilitiesCr | 293 | 223 | 265 | 621 | 973 | 888 | 660 | 345 | 245 | 488 | 1,370 | 1,446 |
Total Liabilities Total LiabilitiesCr |
Current Assets Current AssetsCr | 473 | 581 | 751 | 993 | 1,162 | 1,156 | 1,452 | 2,285 | 2,739 | 2,842 | 3,297 | 2,801 |
Non Current Assets Non Current AssetsCr | 650 | 713 | 1,037 | 1,598 | 1,766 | 2,052 | 2,108 | 2,146 | 2,390 | 3,255 | 4,421 | 5,082 |
Total Assets Total AssetsCr |
| Financial Year | Mar 2015 | Mar 2016 | Mar 2017 | Mar 2018 | Mar 2019 | Mar 2020 | Mar 2021 | Mar 2022 | Mar 2023 | Mar 2024 | Mar 2025 |
|---|
Operating Cash Flow Operating Cash FlowCr | 108 | 167 | 49 | 183 | 60 | 765 | 1,002 | 824 | 650 | 874 | 625 |
Investing Cash Flow Investing Cash FlowCr | -89 | -169 | -353 | -525 | -163 | -428 | -396 | -424 | -276 | -718 | -1,491 |
Financing Cash Flow Financing Cash FlowCr | -22 | 4 | 305 | 345 | 96 | -338 | -599 | -386 | -359 | 44 | 806 |
|
Free Cash Flow Free Cash FlowCr | 18 | 81 | -192 | -438 | -181 | 368 | 790 | 638 | 293 | 139 | -480 |
| 203.8 | 265.9 | 50.9 | 231.6 | 34.7 | 125.1 | 129.1 | 77.2 | 76.3 | 107.8 | 89.6 |
CFO To EBITDA CFO To EBITDA% | 77.6 | 100.3 | 36.2 | 93.2 | 14.6 | 74.5 | 80.3 | 51.4 | 50.4 | 77.8 | 57.2 |
| Financial Year | Mar 2015 | Mar 2016 | Mar 2017 | Mar 2018 | Mar 2019 | Mar 2020 | Mar 2021 | Mar 2022 | Mar 2023 | Mar 2024 | Mar 2025 |
|---|
Valuation Ratios Valuation Ratios |
Market Cap Market CapitalizationCr | 710 | 788 | 1,716 | 3,394 | 3,745 | 5,273 | 22,600 | 30,609 | 25,128 | 28,938 | 27,043 |
Price To Earnings Price To Earnings | 14.0 | 13.2 | 17.8 | 43.0 | 21.6 | 8.6 | 29.1 | 28.7 | 29.5 | 35.7 | 38.8 |
Price To Sales Price To Sales | 0.5 | 0.6 | 1.3 | 2.1 | 1.4 | 1.3 | 5.2 | 4.5 | 3.1 | 3.8 | 3.3 |
Price To Book Price To Book | 2.1 | 1.7 | 2.4 | 3.7 | 3.5 | 3.4 | 9.6 | 9.2 | 6.1 | 6.0 | 5.0 |
| 8.4 | 7.3 | 16.9 | 21.5 | 11.7 | 6.1 | 18.6 | 19.3 | 19.5 | 25.6 | 25.6 |
Profitability Ratios Profitability Ratios |
| 37.0 | 39.9 | 38.3 | 37.1 | 39.0 | 43.9 | 48.1 | 39.5 | 32.9 | 31.8 | 30.1 |
| 10.5 | 12.2 | 9.9 | 11.9 | 15.3 | 24.3 | 28.6 | 23.6 | 16.2 | 14.6 | 13.2 |
| 4.0 | 4.6 | 7.0 | 4.8 | 6.4 | 14.4 | 17.8 | 15.7 | 10.7 | 10.6 | 8.4 |
| 12.9 | 14.3 | 12.9 | 8.7 | 16.0 | 35.2 | 38.0 | 40.2 | 28.1 | 21.9 | 14.7 |
| 15.3 | 13.3 | 13.5 | 8.6 | 16.2 | 38.9 | 33.1 | 31.9 | 20.8 | 16.9 | 12.9 |
| 4.7 | 4.9 | 5.4 | 3.0 | 5.9 | 19.0 | 21.8 | 24.1 | 16.6 | 13.3 | 9.0 |
Operational Ratios Operational Ratios |
Solvency Ratios Solvency Ratios |
Liquidity Ratios Liquidity Ratios |
### **Company Overview**
**Deepak Nitrite Limited (DNL)** is a leading Indian manufacturer of chemical intermediates with over five decades of industry presence. Headquartered in Vadodara, Gujarat, DNL operates through a fully integrated model across the chemical value chain—from core chemical processes like nitration and hydrogenation to high-value specialty and performance chemicals. The company serves over 1,500 customers in more than **50 countries** across six continents, positioning itself as a “Supplier of Choice” for global pharmaceutical, agrochemical, and industrial clients.
DNL’s product portfolio is organized into two primary reportable segments under Ind AS:
1. **Advanced Intermediates**
2. **Phenolics**
It manufactures over **34 premium chemical intermediates** across **56+ applications**, including sodium nitrite, phenol, acetone, IPA, xylidines, oximes, toluidines, and optical brightening agents (OBA). The company operates **seven state-of-the-art manufacturing plants** in five strategic Indian locations: Nandesari, Dahej, and Sankarda (Gujarat); Taloja and Roha (Maharashtra); and Hyderabad (Telangana), with two additional sites under development.
With a strong focus on **import substitution**, **Atmanirbhar Bharat**, and the **‘Make in India, Make for the World’** initiative, DNL aims to reduce India’s dependency on imported chemicals and emerge as a global hub for specialty chemicals.
---
### **Key Strategic Initiatives (as of Oct 2025)**
#### **1. Inauguration of DRDC 2.0 – Next-Gen R&D Center (October 2025)**
- DNL inaugurated **DRDC 2.0** in Savli, Vadodara, a **5-acre greenfield R&D campus** featuring cutting-edge laboratories, pilot plants, and AI-driven research tools.
- The center, built at a cost of **over ₹100 crores**, aims to:
- Accelerate innovation in **sustainable chemistry**, **green processes**, and **high-performance materials**.
- Expand in-house R&D capabilities with **100+ professionals**, including multiple PhDs.
- Drive product innovation in **pharmaceuticals**, **agrochemicals**, **advanced intermediates**, and **material sciences**.
- The facility is intended to transform DNL into a **knowledge-driven chemical enterprise**, reducing time-to-market for new products.
#### **2. Fully Integrated Polycarbonate (PC) Project – India’s First (Timeline: Dec 2027)**
- Through its wholly-owned subsidiary **Deepak Chem Tech Limited (DCTL)**, DNL is building **India’s first integrated polycarbonate (PC) resin plant** at Dahej, Gujarat, with an annual capacity of **165,000 metric tonnes**.
- The project includes:
- Relocation and re-commissioning of **formerly Trinseo assets** from Stade, Germany.
- Licensing of **CALIBRE™**, Trinseo’s trademark and proprietary technology.
- Secured **15-year propylene supply agreement** with Petronet LNG (250,000 MTPA).
- Applications: EV battery casings, medical devices, aerospace, defense, electronics, electronics, construction, and drones.
- **Market Impact**: India currently imports ~400,000 MTPA of PC resins. This project will address over 40% of domestic demand upon full operation.
#### **3. Vertical Integration Across the Phenolics Chain (₹8,500 Crore Investment)**
- DNL is building **fully backward- and forward-integrated production capabilities** across the phenol–acetone–BPA–PC value chain:
- **Greenfield Phenol–Acetone–IPA Complex** (Savli): 300 KTA Phenol, 185 KTA Acetone, 100 KTA IPA.
- **MIBK and MIBC Solvent Plants**: Convert acetone into high-margin solvents for pharmaceuticals, electronics, and coatings.
- **White Nitric Acid (WNA) and Concentrated Nitric Acid (CNA) Plants**: Strengthen upstream integration for nitrated products.
- This integration will allow **over 50% of base chemical output** to be converted into **high-value derivatives**, enhancing margins and EBITDA.
#### **4. Expansion into Specialty Polymers and High-Growth Platforms**
- **MMA/PMMA Resins**: India is 100% import-dependent. DNL plans to produce these transparent, high-durability polymers for automotive and electronics sectors.
- **Aniline Production**: For high-grade aramid applications in defense, not standard PU-grade, ensuring premium margin products.
- **Fluorination and Photochlorination Platforms**: To manufacture critical intermediates for agrochemicals, semiconductors, and precision agriculture.
- DNL is also developing **first-of-its-kind processes**, including patented routes for high-carbon-footprint reduction via low-waste chemistry.
#### **5. Sustainability and Decarbonization**
- DNL has adopted a **60–70% renewable energy target by FY2027**, with:
- **Commercial PPAs** in place since 2026.
- Expected **eCO₂ reduction of 60–65%**.
- **Cost savings** in energy due to renewable PPA.
- Investments in **multifuel boilers**, **low-energy ETP**, **waste recovery**, and **byproduct valorization** (e.g., Acetophenone recovery from phenol waste stream).
---
### **Operational Highlights (Q2 FY2025–26)**
#### **Capacity Commissioning Milestones:**
| Project | Commissioning Status (Oct 2025) |
|---------------------------|------------------------------------------------------|
| **Hydrogenation Facility**| Trial production started, full ramp-up Q2 FY25–26 |
| **WNA (White Nitric Acid)**| Trial commissioning; full capacity by Q2 FY25–26 |
| **MIBK–MIBC Solvent Plant**| Final stage of commissioning; ramp-up to begin |
| **Nitric Acid Plant** | Fully operational; benefits from Q3 FY25–26 onward |
| **PC Compounding Plant** | Already operational since FY25; serving EV and medtech sectors |
#### **Financial & Operational Impact:**
- Nitric acid project to improve **EBITDA by 2–3%** and **Advanced Intermediates segment margin by 200–300 bps**.
- MIBK/MIBC ramp expected to be **faster than 12 months** due to high customer interest (cosmetics, high-margin pharma).
- **Advanced Process Controls (APC)** with AI-based real-time optimization rolled out across seven sites, making DNL **one of the few Indian chemical firms using large-scale APC**.
---
### **Subsidiaries Driving Transformation**
1. **Deepak Phenolics Limited (DPL)**
- Market leader in India for **phenol, acetone, and IPA**.
- Contributed **~69% of DNL’s revenue** in FY24–25.
- Capacity: 300 KTA Phenol, 185 KTA Acetone, 60 KTA IPA.
2. **Deepak Chem Tech Limited (DCTL)**
- Primary vehicle for DNL’s **specialty chemicals and polymer future**.
- Executing **₹8,500 crore investment** in phenol–polycarbonate value chain.
- Holds **CALIBRE™** brand and technology rights.
- Signed binding term sheets with **Petronet LNG** and **Gujarat Government**.
3. **Deepak Oman Industries (DOIL)**
- **51% owned subsidiary** producing **sodium nitrite/nitrate** in Oman using low-cost feedstock and energy.
- Enhances competitiveness in export markets.
---
### **R&D and Innovation Ecosystem**
- **Deepak Research & Development Centre (DRDC), Nandesari**: Government-recognized, with:
- **77 patent applications filed (22 granted)** as of Oct 2025.
- Focus: Sustainable processes, process intensification, and green technologies.
- **Two Pilot Plants (Roha, Nandesari)**: Bridge lab R&D to commercial scale for agrochemicals, pharmaceuticals, and dyes.
- **Digital Twin & tEG Platform**: Real-time supply chain optimization using AI, IoT, and cloud analytics.
- **AI and Digitalization**: Deployed across procurement, logistics, manufacturing, and lab systems.
---
### **Strategic Differentiation**
- **Vertical Integration:** Unique position from ammonia to amines to polycarbonates.
- **Import Substitution Champion:** Already replaced imports of sodium nitrite, phenol, acetone, IPA; expanding to PC, MMA, BPA.
- **Global Positioning:** ~77.5% of revenue from India (domestic resilience), only **2.5–3% from the U.S.**, minimizing tariff risks.
- **China+1 Winner:** Indian manufacturing strength, skilled workforce, and sustainability edge make DNL an ideal supplier for global re-shoring.
- **Backed by Policy:** Aligned with **Make in India**, **Atmanirbhar Bharat**, **PLI Schemes**, and Gujarat’s PCPIR ecosystem.